DYSMORPHOPHOBIA IN DERMATOLOGICAL PRACTICE


Cite item

Full Text

Abstract

The incidence of dysmorphophobia in dermatological patients is much higher than in the population (0,7— 2,4%), reaching 6,7 to 14%, according to epidemiological data. The increasing number of available cosmetological procedures, mainly aimed at improvement of the skin status, has attracted special attention to dysmorphophobia problem in clinical dermatology in recent years. Examinations of dermatological patients (90 cases) enabled us to distinguish two polar dysmorphophobia types by the anxiety criterion (intensity of clinically significant anxiety in various social situations because of imagined or minimally represented physical effect): with externally oriented psychopathological disorders and internal perfectionalism. These types differ by the structure of the psychopathological syndrome, premorbid status, social adaptation level, dermatological consultation rate, presence and intensity of autodestructive actions, comorbid psychopathological disorder, and response to psychopharmacotherapy.

About the authors

I. Yu Dorozhenok

I.M. Setchenov First Moscow State Medical University; Research Center of Mental Health

Email: idoro@bk.ru
кандидат мед. наук, доцент Moscow, Russia

E. N Matyushenko

I.M. Setchenov First Moscow State Medical University

Email: matyushenko@mail.ru
кандидат мед. наук, врач-психиатр Moscow, Russia

O. Yu Olisova

I.M. Setchenov First Moscow State Medical University

доктор мед. наук, профессор Moscow, Russia

References

  1. Phillips K.A., Dufresne R.G. Jr., Wilkel C.S., Vittorio C.C. Rate of body dysmorphic disorder in dermatology patients. J. Am. Acad. Dermatol. 2000; 42(3): 436—41.
  2. Bowe W.P., Leyden J.J., Crerand C.E., Sarwer D.B., Margolis D.J. Body dysmorphic disorder symptoms among patients with acne vulgaris. J. Am. Acad. Dermatol. 2007; 57(2): 222—30.
  3. Conrado L.A., Hounie A.G., Diniz J.B., Fossaluza V., Torres A.R., Miguel E.C., Rivitti E.A. Body dysmorphic disorder among dermatologic patients: Prevalence and clinical features. J. Am. Acad. Dermatol. 2010; 63(2): 235—43. doi: 10.1016/j. jaad.2009.09.017.
  4. Смулевич А.Б., Иванов О.Л., Львов А.Н., Дороженок И.Ю. Психодерматология: современное состояние проблемы. Журнал неврологии и психиатрии им. С.С.Корсакова. 2004; 10: 4—13
  5. Смулевич А.Б. Психические расстройства в дерматологической клинике. Психические расстройства в общей медицине. 2006; 1: 4—9
  6. Sarwer D.B., Crerand C.E. Body image and cosmetic medical treatments. Body Image. 2004; 1(1): 99—111.
  7. Uzun O., Baçoglu C., Akar A., Cansever A., Ozçahin A., Cetin M., Ebrinç S. Body dysmorphic disorder in patients with acne. Com-pr. Psychiatry. 2003; 44(5): 415—9.
  8. Veale D., Neziroglu F. Body dysmorphic disorder: a treatment manual. Chichester, UK: John Wiley and Sons Ltd.; 2010.
  9. Albertini R.S., Phillips K.A. Thirty-three cases of body dysmorphic disorder in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry.1999; 38(4): 453—9.
  10. Phillips K.A., Diaz S.F. Gender differences in body dysmorphic disorder. J. Nerv. Ment. Dis. 1997; 185(9): 570—7.
  11. Mallon E., Newson R., Bunker C.B. HLA-Cw6 and the genetic predisposition to psoriasis: a meta-analysis of published serologic studies. J. Invest. Dermatol. 1999; 113(4): 693—5.
  12. Veale D., Boocock A., Gournay K., Dryden W., Shah F., Willson R., Walburn J. Body dysmorphic disorder: a survey of fifty cases. Br. J. Psychiatry. 1996; 169(2): 196—201.
  13. Phillips K.A., Hollander E., Rasmussen S.A., Aronowitz B.R., DeCaria C., Goodman W.K. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol. Bull. 1997; 33(1): 17—22.
  14. Морозов П.В. Юношеская шизофрения с дисморфоманическими расстройствами: Автореф. дис. ... канд. мед. наук. М.; 1977
  15. Коркина М.В. Дисморфомания в подростковом и юношеском возрасте. М.: Медицина; 1984
  16. Смулевич А.Б., Дороженок И.Ю., Романов Д.В., Львов А.Н. Психопатология психических расстройств в дерматологической клинике (модель психической патологии, ограниченной пространством кожного покрова). Психические расстройства в общей медицине. 2012; 1: 4—14
  17. Ware J.E. Measuring patients views: the optimum outcome measure. Br. Med. J. 1993; 306(6890): 1429—30.
  18. Finlay A.Y. Quality of life assessments in dermatology. Semin. Cutan. Med. Surg. 1998; 17(4): 291—6.
  19. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 1983; 67(6): 361—70.
  20. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischman R.L., Hill C.L., et al. The yale-brown obsessive-compulsive scale. I. Development, use, and reliability. Arch. Gen. Psychiatry. 1989; 46(11): 1006—11.
  21. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychol. Rep. 1962; 10: 799—812.
  22. Lingjaerde О., Ahlfors U.G., Bech P. The UKU side-effect rating scale. A new comprehensive rating scale for psychotropic drugs and cross-sectional study of side-effects in neuroleptic treated patients. Acta Psychiatr. Scand. 1987; 76(Suppl. 334): 1—100.
  23. Hewitt P.L., Flett G.L. Perfectionism: theory, research and treatment. Washington, DC; 2002.

Copyright (c) 2014 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies